Effective Treatment against ESBL-Producing <i>Klebsiella pneumoniae</i> through Synergism of the Photodynamic Activity of Re (I) Compounds with Beta-Lactams

Effective Treatment against ESBL-Producing <i>Klebsiella pneumoniae</i> through Synergism of the Photodynamic Activity of Re (I) Compounds with Beta-Lactams

Background: Extended-spectrum beta-lactamase (ESBL) and carbapenemase (KPC<sup>+</sup>) producing <i>Klebsiella pneumoniae</i> are multidrug-resistant bacteria (MDR) with the highest risk to human health. The significant reduction of new antibiotics development can be overcom...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Iván A. González, Annegrett Palavecino, Constanza Núñez, Paulina Dreyse, Felipe Melo-González, Susan M. Bueno, Christian Erick Palavecino
Format: article
Langue:EN
Publié: MDPI AG 2021
Sujets:
photodynamic therapy
multi-drug resistance
antibiotic synergy
<i>Klebsiella pneumoniae</i>
Pharmacy and materia medica
RS1-441
Accès en ligne:https://doaj.org/article/a4441cf2c8494ccf9bdf02e9c30745ef
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Internet

https://doaj.org/article/a4441cf2c8494ccf9bdf02e9c30745ef

Documents similaires